Ben Tre Pharmaceutical JSC (STC:DBT) Total Receivables: ₫246,050 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:DBT Ben Tre Pharmaceutical JSC STC:DBT
14 GF Score
Price ₫13,500.00
! 1 Warning Sign
View Full Analysis

What is Ben Tre Pharmaceutical JSC Total Receivables?

Ben Tre Pharmaceutical JSC STC:DBT -0.38% 14 Total Receivables is ₫246,050 Mil as of Dec. 2025. GuruFocus rates STC:DBT with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Ben Tre Pharmaceutical JSC's Total Receivables for the quarter that ended in Dec. 2025 was ₫246,050 Mil.

Ben Tre Pharmaceutical JSC Total Receivables Related Terms

Ben Tre Pharmaceutical JSC Total Receivables Historical Data

* Premium members only.

The historical data trend for Ben Tre Pharmaceutical JSC's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ben Tre Pharmaceutical JSC Total Receivables Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 179,026.03 209,330.02 228,694.72 184,125.98 246,049.83

Ben Tre Pharmaceutical JSC Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 228,694.72 216,593.49 184,125.98 220,253.98 246,049.83
STC:DBT
14GF Score
Ben Tre Pharmaceutical JSC STC:DBT
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ben Tre Pharmaceutical JSC Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of ₫246,050 Mil mean?
Ben Tre Pharmaceutical JSC (STC:DBT) has a Total Receivables of ₫246,050 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ben Tre Pharmaceutical JSC and its competitors.
Is Ben Tre Pharmaceutical JSC's Total Receivables too high?
Ben Tre Pharmaceutical JSC's current Total Receivables is ₫246,050 Mil. Overall, Ben Tre Pharmaceutical JSC has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Ben Tre Pharmaceutical JSC's Total Receivables compare to ZTS and UTHR?
Ben Tre Pharmaceutical JSC's Total Receivables of ₫246,050 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Ben Tre Pharmaceutical JSC and its competitors. Ben Tre Pharmaceutical JSC's current Total Receivables is ₫246,050 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ben Tre Pharmaceutical JSC stock overvalued right now?
Ben Tre Pharmaceutical JSC (STC:DBT) has a current Total Receivables of ₫246,050 Mil. The current Total Receivables is ₫246,050 Mil. Ben Tre Pharmaceutical JSC's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Ben Tre Pharmaceutical JSC (STC:DBT), the current Total Receivables is ₫246,050 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ben Tre Pharmaceutical JSC Business Description

Address No. 6A3, National Highway 60, Phu Tan Ward, Vinh Long Province, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is a Vietnamese pharmaceutical company headquartered in Ben Tre province. It manufactures, imports, and distributes a range of healthcare products, including prescription and over-the-counter medicines, functional foods, vaccines, cosmetics, and medical equipment and machinery. The company also trades in testing chemicals and biological products, and produces pharmaceuticals, chemicals, and medicinal herbs. Its operations span manufacturing, wholesale and retail distribution, and import-export activities, serving hospitals, clinics, pharmacies, and healthcare providers across Vietnam. In addition, it leases warehouses and premises, generating rental income alongside its core pharmaceutical business. Revenue comes primarily from the sale and distribution of medicines and healthcare products, supplemented by manufacturing, trading, and property leasing activities.
14GF Score

Get the complete analysis for STC:DBT

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫13,500.00
Price